{"id":"053517422063-07","name":"Mundipharma International Limited","registrationDate":"2016-06-01T19:42:12.690+01:00","category":2,"subCategory":3,"legal":"Priviate Limited Company","web":"http://www.mundipharma.com/","country":"United kingdom","headAddress":"Mundipharma International Limited","headCity":"Cambridge","headPostCode":"CB4 0AB","headPhone":"(44)12 23 42 42 11","boss":"Antony Mattessich","bossTitle":"Mr","bossPosition":"Managing Director","membersCount":1,"membersFTE":"0.25","membership":"","memberOrga":"","goal":"Mundipharma and its in network of dependent associated companies are privately owned companies and joint ventures covering the world's pharmaceutical markets. &#xd;<br />These companies are committed to bringing to patients the benefits of significant new treatment options. &#xd;<br />&#xd;<br />Mundipharma works with patients, policy-makers at national and EU level, and payers to drive further improvements in treatments across the addiction ecosystem.","acronym":"","interests":"Communication, Home Affairs, Internal Market, Public Health, Research and Technology","euInitiatives":"The network of Mundipharma International Limited associated companies is developing a portfolio of medicines for people living with addiction. Mundipharma International recently responded to the European Commission?s consultation on EU Drugs Strategy.","lastUp":"2017-06-09T12:35:35.182+01:00","customers":"","costAbsolu":"","costRange":"0-9999","turnoverAbsolu":0,"turnoverRange":""}